Management of Submacular Hemorrhage-Reference-Cited by-同舟云学术

Management of Submacular Hemorrhage

Published:2022-10-26 Issue:12 Volume:10 Page:231-238
ISSN:2167-4817
Container-title:Current Surgery Reports
language:en
Short-container-title:Curr Surg Rep

Author:

Mohammed Taariq K.,Simon Caroline L.,Gorman Emily F.,Taubenslag Kenneth J.

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s40137-022-00330-z.pdf

Reference56 articles.

1. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd. 1999;213(2):97–102.

2. Treumer F, Roider J, Hillenkamp J. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage. Br J Ophthalmol. 2012;96(5):708–13.

3. • Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, et al. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience. Ophthalmol Retina. 2018 Mar;2(3):180–6. Subretinal air may aid in achieving consistent hemorrhage displacment.

4. Lim JH, Han YS, Lee SJ, Nam KY. Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration. PLoS ONE. 2020;15(12): e0243201.

5. Bae K, Cho GE, Yoon JM, Kang SW. Optical coherence tomographic features and prognosis of pneumatic displacement for submacular hemorrhage. PLoS ONE. 2016;11(12): e0168474.